SHELCAL 250MG TABLET contains Calcium Carbonate, Cholecalciferol (Vitamin D3) and Elemental Calcium which belong to the group of medicines called Calcium and Vitamin D3 Supplements. It is used for the management of calcium and vitamin D3 deficiency.

SHELCAL 250MG TABLET is not recommended for use in patients suffering from Hypervitaminosis D, severe kidney disorder, kidney failure, nephrolithiasis/nephrocalcinosis (kidney stones), diseases which cause hypercalcaemia (high calcium levels in the blood) and hypercalciuria (high calcium in the urine) such as myeloma, bone metastases, primary hyperparathyroidism, rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.

SHELCAL 250MG TABLET should be used with caution in patients suffering from kidney disease or reduced kidney function or who are prone to the development of kidney stones, sarcoidosis (an inflammatory disease affecting multiple organs), or immobilised patients with a risk of osteoporosis.

SHELCAL 250MG TABLET may be used during pregnancy in cases of calcium and vitamin D3 deficiency. SHELCAL 250MG TABLET can be used by breastfeeding women. In elderly patients suffering from systemic disorders, SHELCAL 250MG TABLET should be used with caution. Consult your doctor immediately if you experience any side effects after taking SHELCAL 250MG TABLET.